Skip to main content
Equibles

UBS Group AG

Position in ANIX — Anixa Biosciences Inc

CIK 1610520 ZURICH, V8
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,639,203
+$215,981 QoQ
Shares Held
585,430
+6.1% QoQ
Ownership
1.72%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 13% Shared 0% None 87%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ANIX ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,639,203 585,430
2026-03-31 $1,423,222 551,637
2025-12-31 $1,432,306 459,073
2025-09-30 $1,565,783 474,480
2025-06-30 $1,667,456 505,290
2025-03-31 $1,499,102 524,162
2024-12-31 $1,239,166 534,124
2024-09-30 $1,667,603 529,398
2024-06-30 $1,172,493 530,540
2024-03-31 $1,673,277 536,307
2023-12-31 $2,252,642 580,578
2023-09-30 $1,976,515 604,439
2023-06-30 $2,029,692 634,279
2023-03-31 $2,747,682 638,996
2022-12-31 $2,645,810 622,544
2022-09-30 $3,058,719 621,691
2022-06-30 $1,852,541 605,406
2022-03-31 $1,639,728 598,441
2021-12-31 $1,769,522 595,799
2021-09-30 $2,778,085 582,408
2021-06-30 $2,666,730 687,302
2021-03-31 $2,749,410 587,481
2020-12-31 $1,898,006 618,243
2020-09-30 $1,283,144 528,043
2020-06-30 $1,593,626 520,793
2020-03-31 $543,215 341,645